Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLOD2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | ITPR2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | HES2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | FRAT2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | GRK2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | IGSF6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | TGFB1I1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | PHLDA3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | OR2A7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | FAM109A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |